Tevogen Bio Warrant (TVGNW)

• Market cap: $7.82M
• 1 day: 6.52%
• 5 days: 6.25%
• 1 month: 0.71%
• 3 months: -16.01%
• 6 months: -33.07%
• Year to date: 1.43%
• 1 year: -43.18%
• 5 years: -90.56%
• 10 years: -90.56%
• Sector: Healthcare
• Industry: Biotechnology

About: Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Employees: 17